ANTEIS S.A. Patent applications |
Patent application number | Title | Published |
20140194850 | ACCESSORY FOR A SYRINGE - An accessory for a syringe is disclosed, including a body with a proximal end having at least one zone for application of an injection force in order to apply a force for discharging a product from the syringe, and a distal end having a bearing element for bearing against a needle mounted on the mouth of the syringe with a force that includes a radial component perpendicular to the longitudinal axis of the syringe and directed towards the centre of the syringe. An assembly including such an accessory and a syringe is also disclosed. | 07-10-2014 |
20140162975 | VISCOELASTIC GEL FOR DERMATOLOGICAL USE - The invention relates to a polysaccharide gel of natural origin for dermatological use that comprises an aqueous solution of the polysaccharide of 0.1 to 5% by weight/volume, for example hyaluronic acid, and a viscous and strongly hydrophilic biocompatible alcohol at 0.5-5% by weight/volume, for example glycerol, and optionally the adjuvants that are commonly used in dermatology. The gel is prepared by mixing the polysaccharide solution and the strongly hydrophilic viscous alcohol before sterilizing the entire mixture by, for example, moist heat. | 06-12-2014 |
20140038917 | STERILE AND INJECTABLE AQUEOUS FORMULATION FOR ADMINISTRATION IN THE INTRA-ARTICULAR SPACE OF AN INTRA-ARTICULAR JOINT - The present invention relates generally to the treatment and/or prevention of pain associated with an intra-articular joint degeneration or disease. This invention concerns in particular a sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint of a subject, in the form of a gel. | 02-06-2014 |
20130274224 | STERILE INJECTABLE AQUEOUS FORMULATION USED IN OPHTHALMOLOGY - The present invention relates to an intraocularly injectable sterile aqueous formulation based on a mixture of hyaluronic acid and alginate, or a salt thereof, used in ophthalmology and having specific viscoelasticity, spreading, covering and ocular tissue adhesion properties and also a high capacity for neutralizing free radicals, said properties enabling said composition to strongly protect the eye tissues. | 10-17-2013 |
20130006218 | Assisted Injection Device - Assisted injection device including a container for containing a product to be injected, the container including a movable bottom; a needle attached to the end of the container opposite the movable bottom; a piston acting on the movable bottom to expel through the needle a product located in the container and which is to be injected; a rotary motor for moving the piston by means of a drive mechanism, which converts the rotary motion of the rotary motor into a linear motion of the piston, the piston acting on the movable bottom by means of a compressible damping element. | 01-03-2013 |
20120108674 | INJECTABLE HYDROGEL FOR THE LONG-TERM SUPPLEMENTATION OF GLYCEROL IN THE SKIN - An injectable hydrogel, includes, in weight, in a physiologically acceptable carrier fluid: 0.01 to 5% of glycerol and 0.1 to 5% of cross-linked hyaluronic acid, or one of the salts thereof; characterized in that the hyaluronic acid or one of the salts thereof is cross-linked by the formation of covalent bonds using bifunctional or polyfunctional molecules, the injectable hydrogel being sterilized in moist heat and having viscoelastic properties such that TanĪ“ at a frequency of 1 Hz is less than or equal to 1.10. A method for producing the hydrogel, to a kit containing the hydrogel, as well as to the use thereof in dermatology are also described. | 05-03-2012 |
20110230438 | VISCOELASTIC GEL FOR DERMATOLOGICAL USE - The invention relates to a polysaccharide gel of natural origin for dermatological use that comprises an aqueous solution of the polysaccharide of 0.1 to 5% by weight/volume, for example hyaluronic acid, and a viscous and strongly hydrophilic biocompatible alcohol at 0.5-5% by weight/volume, for example glycerol, and optionally the adjuvants that are commonly used in dermatology. The gel is prepared by mixing the polysaccharide solution and the strongly hydrophilic viscous alcohol before sterilizing the entire mixture by, for example, moist heat. | 09-22-2011 |
20110201571 | HEAT STERILISED INJECTABLE COMPOSITION OF HYALURONIC ACID OR ONE OF THE SALTS THEREOF, POLYOLS AND LIDOCAINE - An injectable aqueous composition of hyaluronic acid or one of the salts thereof, one or more polyol(s) and lidocaine is used for cosmetic purposes or for therapeutic purposes. It has improved viscoelastic rheological properties and long in vivo persistence. The polyol is chosen, for example, from glycerol, sorbitol, propylene glycol, mannitol, erythritol, xylitol, maltitol and lactitol. The particular properties are obtained by heat sterilising the mixture. | 08-18-2011 |
20100184720 | USE OF A NATURAL POLYSACCHARIDE GEL FOR THE PREPARATION OF AN INJECTABLE FORMULATION FOR TREATMENT OF ARTICULAR DEGENERATION - A sterile injectable aqueous formulation in the form of a gel is made up of hyaluronic acid (or one of the salts thereof) with or without other natural polysaccharide(s) and one or more polyols. The formulation is of intra-articular application in the treatment of joint degeneration, in some cases having a rheology similar to that of synovial liquid and always with an elevated resistance to degradation due to a synergistic action between the hyaluronic acid and the polyols. | 07-22-2010 |
20100069938 | GLAUCOMA SURGERY - Eye diseases such as glaucoma can be treated using a composition containing cross-linked hyaluronic acid or a cross-linked salt of hyaluronic acid such as sodium hyalurate. The composition can be a monophasic gel. The composition can include a cross-linking agent such as 1,4-butanediol diglycidylether. The composition can contains about 2.25% (w/w) of the salt of hyaluronic acid. The composition can have a cross-linking rate of about 0.5 to 50%. | 03-18-2010 |
20100028435 | INJECTABLE HYDROGEL WITH AN ENHANCED REMANENCE AND WITH AN ENHANCED ABILITY TO CREATE VOLUME - An injectable hydrogel includes a hydrogel matrix based on (a) single-phase-type cross-linked biopolymer(s), characterized in that previously cross-linked biopolymer hydrogel particles are co-cross-linked with the matrix. A method of and a process for production of the above-mentioned hydrogel are also disclosed. | 02-04-2010 |